23,036,271
Vote Records
25,695
Companies
11,771
Funds
3,902
Managers

Home › Companies › BIOGEN INC. › 2023-2024

BIOGEN INC. 2023-2024 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and BIOGEN INC.’s Form 8-K, filed June 25, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 14Reported items
  • 875Asset managers, any item
  • 12,171Fund votes
  • June 20, 2024Meeting date

Results at a glance

Meeting of June 20, 2024: 14 items on BIOGEN INC.’s Form 8-K, filed June 25, 2024: 5 approved · 9 passed (calculated).

Dissent

Significant dissent: 2 directors (26.4%, 22.5% against).

Notable dissent: 5 directors (19.7%, 19.2%, 16.6%, 15.7%, 15.3% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BIOGEN INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by BIOGEN INC.

These tallies are BIOGEN INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 25, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIOGEN INC. — official shareholder meeting results, meeting held June 20, 2024
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Caroline D. Dorsa 87,883,98131,591,98484,665 --9,672,399 74%Passed (calculated)—
Elect Director: Maria C. Freire 100,691,87018,771,13997,621 --9,672,399 84%Passed (calculated)—
Elect Director: William A. Hawkins 95,931,54923,539,59589,486 --9,672,399 80%Passed (calculated)—
Elect Director: Susan K. Langer 92,603,94826,870,91985,763 --9,672,399 78%Passed (calculated)—
Elect Director: Jesus B. Mantas 99,615,56219,856,50188,567 --9,672,399 83%Passed (calculated)—
Elect Director: Monish Patolawala 119,078,211388,22794,192 --9,672,399 99.7%Passed (calculated)—
Elect Director: Eric K. Rowinsky 96,514,37222,954,34891,910 --9,672,399 81%Passed (calculated)—
Elect Director: Stephen A. Sherwin 101,152,83718,318,06889,725 --9,672,399 85%Passed (calculated)—
Elect Director: Christopher A. Viehbacher 118,593,483886,74380,404 --9,672,399 99.3%Passed (calculated)—
2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast 123,728,4185,348,316156,295 ---- 96%Approved—
3. Advisory vote on executive compensation, with the votes cast 114,367,7995,054,473138,358 --9,672,399 96%Approved—
4. The amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision, with the votes cast 103,146,57816,274,796139,256 --9,672,399 86%Approved—
5. Stockholders approved the adoption of the Biogen Inc. 112,726,1696,693,956140,505 --9,672,399 94%Approved—
6. Stockholders approved the adoption of the Biogen Inc. 119,064,435413,47582,720 --9,672,399 99.7%Approved—

Source: BIOGEN INC., Form 8-K, filed with the SEC on June 25, 2024 — read the filing on EDGAR.

How asset managers voted at the BIOGEN INC. 2023-2024 meeting

875 asset managers disclosed a vote on at least one BIOGEN INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIOGEN INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

Elect Director: Caroline D. Dorsa

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%AGAINST
FOR: 87,883,981AGAINST: 31,591,984
Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa

BIOGEN INC.’s own tally for this item (“Elect Director: Caroline D. Dorsa”): 87,883,981 for, 31,591,984 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 74% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 43,775,381 for, 22,844,611 against, 15,868 abstained.

FORAGAINST
FOR: 43,775,381AGAINST: 22,844,611ABSTAIN: 15,868
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard15,931,76117,497,468 00Mixed
BlackRock5,511,1082,243 00For
T. Rowe Price3,323,303897,693 00Mixed
Fidelity3,588,836288,418 00Mixed
PRIMECAP Odyssey Funds02,212,789 00Against
State Street1,762,672284 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan01,241,920 00Against
Invesco1,126,9770 00For
Jackson National1,084,73128,092 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Elect Director: Christopher A. Viehbacher

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 118,593,483AGAINST: 886,743

Prior year: 98.3% for (June 26, 2023 meeting) ▲ 1.0 pts

Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher

BIOGEN INC.’s own tally for this item (“Elect Director: Christopher A. Viehbacher”): 118,593,483 for, 886,743 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 66,618,866 for, 1,125 against, 15,867 abstained.

FOR
FOR: 66,618,866AGAINST: 1,125ABSTAIN: 15,867
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard33,429,2290 00For
BlackRock5,512,579772 00For
T. Rowe Price4,220,9960 00For
Fidelity3,877,2540 00For
PRIMECAP Odyssey Funds2,212,7890 00For
State Street1,762,86789 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Elect Director: Eric K. Rowinsky

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST
FOR: 96,514,372AGAINST: 22,954,348

Prior year: 57.2% for (June 26, 2023 meeting) ▲ 23.6 pts

Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky

BIOGEN INC.’s own tally for this item (“Elect Director: Eric K. Rowinsky”): 96,514,372 for, 22,954,348 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 81% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 50,106,623 for, 16,513,368 against, 15,868 abstained.

FORAGAINST
FOR: 50,106,623AGAINST: 16,513,368ABSTAIN: 15,868
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard20,490,21412,939,015 00Mixed
BlackRock5,511,1082,243 00For
T. Rowe Price3,323,303897,693 00Mixed
Fidelity3,789,99787,257 00For
PRIMECAP Odyssey Funds02,212,789 00Against
State Street1,762,672284 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,410413 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Elect Director: Jesus B. Mantas

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST
FOR: 99,615,562AGAINST: 19,856,501

Prior year: 77.4% for (June 26, 2023 meeting) ▲ 6.0 pts

Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas

BIOGEN INC.’s own tally for this item (“Elect Director: Jesus B. Mantas”): 99,615,562 for, 19,856,501 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 50,266,157 for, 16,353,834 against, 15,868 abstained.

FORAGAINST
FOR: 50,266,157AGAINST: 16,353,834ABSTAIN: 15,868
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard20,490,21412,939,015 00Mixed
BlackRock5,512,579772 00For
T. Rowe Price3,323,303897,693 00Mixed
Fidelity3,789,99787,257 00For
PRIMECAP Odyssey Funds02,212,789 00Against
State Street1,762,88769 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,410413 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Elect Director: Maria C. Freire

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%AGAINST
FOR: 100,691,870AGAINST: 18,771,139

Prior year: 63.7% for (June 26, 2023 meeting) ▲ 20.6 pts

Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire

BIOGEN INC.’s own tally for this item (“Elect Director: Maria C. Freire”): 100,691,870 for, 18,771,139 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 51,466,937 for, 15,153,054 against, 15,869 abstained.

FORAGAINST
FOR: 51,466,937AGAINST: 15,153,054ABSTAIN: 15,869
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard20,490,21412,939,015 00Mixed
BlackRock5,512,579772 00For
T. Rowe Price4,220,9960 00For
Fidelity3,877,2540 00For
PRIMECAP Odyssey Funds02,212,789 00Against
State Street1,762,88769 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Elect Director: Monish Patolawala

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 119,078,211AGAINST: 388,227
Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala

BIOGEN INC.’s own tally for this item (“Elect Director: Monish Patolawala”): 119,078,211 for, 388,227 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 66,619,758 for, 232 against, 15,868 abstained.

FOR
FOR: 66,619,758AGAINST: 232ABSTAIN: 15,868
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard33,429,2290 00For
BlackRock5,513,3510 00For
T. Rowe Price4,220,9960 00For
Fidelity3,877,2540 00For
PRIMECAP Odyssey Funds2,212,7890 00For
State Street1,762,9560 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Elect Director: Stephen A. Sherwin

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST
FOR: 101,152,837AGAINST: 18,318,068

Prior year: 78.2% for (June 26, 2023 meeting) ▲ 6.4 pts

Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin

BIOGEN INC.’s own tally for this item (“Elect Director: Stephen A. Sherwin”): 101,152,837 for, 18,318,068 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 51,349,436 for, 15,270,555 against, 15,868 abstained.

FORAGAINST
FOR: 51,349,436AGAINST: 15,270,555ABSTAIN: 15,868
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard20,490,21412,939,015 00Mixed
BlackRock5,512,579772 00For
T. Rowe Price4,220,9960 00For
Fidelity3,877,2540 00For
PRIMECAP Odyssey Funds02,212,789 00Against
State Street1,762,801155 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Elect Director: Susan K. Langer

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%AGAINST
FOR: 92,603,948AGAINST: 26,870,919
Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer

BIOGEN INC.’s own tally for this item (“Elect Director: Susan K. Langer”): 92,603,948 for, 26,870,919 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 78% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 44,057,451 for, 22,562,540 against, 15,868 abstained.

FORAGAINST
FOR: 44,057,451AGAINST: 22,562,540ABSTAIN: 15,868
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard15,931,76117,497,468 00Mixed
BlackRock5,512,579772 00For
T. Rowe Price3,323,303897,693 00Mixed
Fidelity3,588,836288,418 00Mixed
PRIMECAP Odyssey Funds02,212,789 00Against
State Street1,762,88769 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan01,241,920 00Against
Invesco1,126,9770 00For
Jackson National1,084,73128,092 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Elect Director: William A. Hawkins

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 7 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST
FOR: 95,931,549AGAINST: 23,539,595

Prior year: 61.5% for (June 26, 2023 meeting) ▲ 18.8 pts

Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins

BIOGEN INC.’s own tally for this item (“Elect Director: William A. Hawkins”): 95,931,549 for, 23,539,595 against, per its Form 8-K filed June 25, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 80% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 148 asset managers below reported 46,803,932 for, 19,816,059 against, 15,868 abstained.

FORAGAINST
FOR: 46,803,932AGAINST: 19,816,059ABSTAIN: 15,868
Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard15,931,76117,497,468 00Mixed
BlackRock5,511,1082,243 00For
T. Rowe Price4,220,9960 00For
Fidelity3,864,95112,303 00For
PRIMECAP Odyssey Funds02,212,789 00Against
State Street1,762,759197 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

The amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation…

Official resultCORPORATE GOVERNANCEReported outcome: Approved

Combines 6 wordings of this item as funds reported it.

86% Approved · of votes cast

FOR 86%
FOR: 103,146,578AGAINST: 16,274,796
Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision.

BIOGEN INC.’s own tally for this item (“4. The amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision, with the votes cast”): 103,146,578 for, 16,274,796 against — passed, per its Form 8-K filed June 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders approved the amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision, with the votes cast as follows:”
Support: 86% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of BIOGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Approve Article Amendments” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 148 asset managers below reported 61,543,295 for, 5,076,693 against, 15,871 abstained.

FOR
FOR: 61,543,295AGAINST: 5,076,693ABSTAIN: 15,871
Largest asset managers voting on “To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an o” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard33,429,2290 00For
BlackRock5,509,2504,101 00For
T. Rowe Price4,220,9960 00For
Fidelity3,688,396188,858 00For
PRIMECAP Odyssey Funds2,212,7890 00For
State Street1,762,86987 00For
VanEck ETF Trust01,647,240 00Against
JPMorgan01,241,920 00Against
Invesco1,126,9770 00For
Jackson National1,085,14427,679 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason1,562568,105 00Against
MFS437,3590 00For
First Trust411,9780 00For
Parnassus0360,742 00Against
Brown Advisory Funds0351,630 00Against
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

To approve the Biogen Inc. 2024 Omnibus Plan.

No official matchCORPORATE GOVERNANCE

Combines 4 wordings of this item as funds reported it.

99% of fund votes cast · no official result

FOR
Details: votes by 149 asset managers

The 149 asset managers below reported 65,567,919 for, 781,136 against, 9 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 65,567,919AGAINST: 781,136ABSTAIN: 9
Largest asset managers voting on “To approve the Biogen Inc. 2024 Omnibus Plan.” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard33,429,2290 00For
BlackRock5,513,3510 00For
T. Rowe Price4,220,9960 00For
Fidelity3,877,2540 00For
PRIMECAP Odyssey Funds2,212,7890 00For
State Street1,762,86987 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century0594,866 00Against
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For
ProShares188,1020 00For

Showing the 25 largest of 149 asset managers. All 149 are in the interactive database (link above).

To approve the Biogen Inc. 2024 Employee Stock Purchase Plan.

No official matchCORPORATE GOVERNANCE

Combines 4 wordings of this item as funds reported it.

99.9% of fund votes cast · no official result

FOR
Details: votes by 147 asset managers

The 147 asset managers below reported 66,333,672 for, 15,212 against, 5 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.

FOR: 66,333,672AGAINST: 15,212ABSTAIN: 5
Largest asset managers voting on “To approve the Biogen Inc. 2024 Employee Stock Purchase Plan.” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard33,429,2290 00For
BlackRock5,513,3510 00For
T. Rowe Price4,220,9960 00For
Fidelity3,877,2540 00For
PRIMECAP Odyssey Funds2,212,7890 00For
State Street1,762,9560 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For
ProShares188,1020 00For

Showing the 25 largest of 147 asset managers. All 147 are in the interactive database (link above).

Advisory vote on executive compensation, with the votes cast

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 10 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%
FOR: 114,367,799AGAINST: 5,054,473

Prior year: 69.5% for (June 26, 2023 meeting) ▲ 26.3 pts

Details: description as filed, official tally, votes by 822 asset managers

Description as filed by funds: Say on Pay - To hold an advisory vote on executive compensation.

BIOGEN INC.’s own tally for this item (“3. The advisory vote on executive compensation, with the votes cast”): 114,367,799 for, 5,054,473 against — passed, per its Form 8-K filed June 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of BIOGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (33 managers, 4,104,101 for, 200,983 against, 884 abstained, 2 1 year); “14A Executive Compensation” (23 managers, 97,419 for); “Compensation” (2 managers, 450 for).

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 141 asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard33,429,2290 00For
BlackRock5,513,3510 00For
T. Rowe Price4,220,9960 00For
Fidelity3,877,2540 00For
PRIMECAP Odyssey Funds2,212,7890 00For
State Street1,762,9560 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For
ProShares188,1020 00For

Fund voting reports, all 141 managers: 66,295,264 for, 39,686 against, 14,987 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 703 asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
PRIMECAP MANAGEMENT CO/CA/15,773,6070 00For
T. Rowe Price7,101,3740 00For
BlackRock6,032,7410 00For
Wellington5,019,4560 00For
State Street4,165,3430 00For
GEODE CAPITAL MANAGEMENT, LLC3,429,3160 00For
VAN ECK ASSOCIATES CORP1,650,3550 00For
Beutel, Goodman & Co Ltd.1,541,1500 00For
Clearbridge Investments, LLC1,539,2430 00For
Northern Trust1,360,5422,988 00For
Invesco1,207,9370 00For
Fidelity1,132,7510 00For
MELLON INVESTMENTS Corp1,027,5960 00For
Legal & General Investment Management Ltd0940,950 00Against
Amundi0892,319 00Against
Charles Schwab884,5680 00For
ORBIMED ADVISORS LLC872,9530 00For
RA CAPITAL MANAGEMENT, L.P.732,6200 00For
American Century677,9860 00For
Vanguard632,7920 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/629,0240 00For
UBS603,8580 00For
Goldman Sachs466,1120 00For
Aberdeen456,4170 00For
PICTET ASSET MANAGEMENT SA432,1020 00For

Institutional-manager reports, all 703 managers: 70,111,035 for, 3,595,455 against, 49,226 abstained, 1,782 not voted, 35 unknown. Showing the 25 largest; every one is in the interactive database (link above).

The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 4 wordings of this item as funds reported it.

96% Approved · of votes cast

FOR 96%
FOR: 123,728,418AGAINST: 5,348,316

Prior year: 96.6% for (June 26, 2023 meeting) ▼ 0.8 pts

Details: description as filed, official tally, votes by 148 asset managers

Description as filed by funds: To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024.

BIOGEN INC.’s own tally for this item (“2. The selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast”): 123,728,418 for, 5,348,316 against — passed, per its Form 8-K filed June 25, 2024 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast as follows:”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Also reported under other wordings, matched to the same row of BIOGEN INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Ratify Appointment of Independent Auditors” (2 managers, Fund and manager reports combined; may count the same shares twice; no share total shown).

The 148 asset managers below reported 66,490,374 for, 129,617 against, 15,868 abstained.

FOR
FOR: 66,490,374AGAINST: 129,617ABSTAIN: 15,868
Largest asset managers voting on “To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for” at BIOGEN INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
Vanguard33,429,2290 00For
BlackRock5,513,3510 00For
T. Rowe Price4,220,9960 00For
Fidelity3,877,2540 00For
PRIMECAP Odyssey Funds2,212,7890 00For
State Street1,762,86987 00For
VanEck ETF Trust1,647,2400 00For
JPMorgan1,241,9200 00For
Invesco1,126,9770 00For
Jackson National1,112,8230 00For
Dimensional887,7910 00For
Charles Schwab855,3630 00For
Columbia Threadneedle636,4850 00For
American Century594,8660 00For
Legg Mason569,6670 00For
MFS437,3590 00For
First Trust411,9780 00For
Parnassus360,7420 00For
Brown Advisory Funds351,6300 00For
TIAA337,8280 00For
Voya297,7180 00For
Aberdeen287,6510 00For
Erste Asset Management GmbH266,1610 00For
MASTER INVESTMENT PORTFOLIO227,4620 00For
Goldman Sachs192,1580 00For

Showing the 25 largest of 148 asset managers. All 148 are in the interactive database (link above).

Not shown here: this season’s fund filings also report 1 item from the meeting of June 17, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.

Largest BIOGEN INC. shareholders voting in 2023-2024

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 144,900,000 shares outstanding at the time of that meeting.

Fund voting reports: top BIOGEN INC. shareholders by shares voted on “Say on Pay - To hold an advisory vote on executive compensation.”, 2023-2024
#Asset manager % of shares outstanding
1Vanguard 23.07%
2BlackRock 3.80%
3T. Rowe Price 2.91%
4Fidelity 2.68%
5PRIMECAP Odyssey Funds 1.53%
6State Street 1.22%
7VanEck ETF Trust 1.14%
8JPMorgan 0.86%
9Invesco 0.78%
10Jackson National 0.77%
Institutional-manager reports: top BIOGEN INC. shareholders by shares voted on “Say on Pay - To hold an advisory vote on executive compensation.”, 2023-2024
#Asset manager % of shares outstanding
1PRIMECAP MANAGEMENT CO/CA/ 10.89%
2T. Rowe Price 4.90%
3BlackRock 4.16%
4Wellington 3.46%
5State Street 2.87%
6GEODE CAPITAL MANAGEMENT, LLC 2.37%
7VAN ECK ASSOCIATES CORP 1.14%
8Beutel, Goodman & Co Ltd. 1.06%
9Clearbridge Investments, LLC 1.06%
10Northern Trust 0.94%

Reported BIOGEN INC. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

BIOGEN INC. holdings and ownership disclosed for the 2023-2024 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
Vanguard Group17,289,235 11.93%Form 13F, quarter ended March 31, 2024
BlackRock14,763,952 10.19%Form 13F, quarter ended March 31, 2024
Biogen MA Inc.7,155,243 4.94%Schedule 13G, filed November 7, 2024
State Street6,747,008 4.66%Form 13F, quarter ended March 31, 2024
Wellington Management5,120,142 3.53%Form 13F, quarter ended March 31, 2024
Geode Capital3,409,674 2.35%Form 13F, quarter ended March 31, 2024
Morgan Stanley2,251,535 1.55%Form 13F, quarter ended March 31, 2024
Invesco1,668,017 1.15%Form 13F, quarter ended March 31, 2024
T. Rowe Price1,589,629 1.10%Form 13F, quarter ended March 31, 2024
Northern Trust1,388,386 0.96%Form 13F, quarter ended March 31, 2024

Percentages above are of 144,900,000 shares outstanding, as reported by BIOGEN INC. on its Form 10-K dated December 31, 2023 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At BIOGEN INC.'s shareholder meeting held June 20, 2024, in the 2023-2024 proxy season, 875 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 12,171 separate fund positions. Their filings are grouped here into 14 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Say on Pay - To hold an advisory vote on executive compensation. — BIOGEN INC.'s filing reports the proposal as approved, with 96% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BIOGEN INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 25, 2024.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIOGEN INC.’s 10-K dated December 31, 2023. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

BIOGEN INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.

Cite this page

Proxy Votes Now, “BIOGEN (BIIB) 2024 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/biogen-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.